Genetic background and diagnosis of Fanconi anemia
- 31 December 2020
- journal article
- review article
- Published by Walter de Gruyter GmbH in Postępy Higieny I Medycyny Doświadczalnej
- Vol. 74, 589-600
- https://doi.org/10.5604/01.3001.0014.6332
Abstract
Fanconi anemia (FA) is a rare genetic disease caused by mutations in genes whose protein products are involved in important cell processes such as replication, cell cycle control and repair of DNA damage. FA is characterized by congenital malformations, bone marrow failure and high risk of cancer. Phenotypic symptoms, present in about 75% of patients, most often include such abnormalities as short stature, microcephaly, thumb and radial side of the limb defects, abnormal skin pigmentation, gastrointestinal and genitourinary defects. Progressive bone marrow failure occurs in the first decade of life, often initially with leukopenia or thrombocytopenia. The most common cancers occurring in patients with FA are myelodysplastic syndromes and acute myeloid leukemia, as well as solid tumors of the head and neck, skin, gastrointestinal system and genitourinary system. So far, 22 genes of Fanconi anemia (FANC) have been identified, which are located on the autosomal chromosomes, except for FANCB, which is located on the X chromosome. Protein products of FANC genes are the elements of Fanconi anemia pathway, which regulates DNA damage repair systems. Genetic diagnostics of Fanconi anemia should start by testing crosslinking agents: mitomycin C (MMC) or diepoxybutane (DEB) assuring differential diagnosis of chromosome instability syndromes. In patients with Fanconi anemia, an increased number of chromosomal gaps and breaks as well as specific radial structures are observed. In order to detect a mutation underlying Fanconi anemia, molecular techniques should be used, preferentially next generation sequencing (NGS).Keywords
This publication has 64 references indexed in Scilit:
- HMGA1: A Master Regulator of Tumor Progression in Triple-Negative Breast Cancer CellsPLOS ONE, 2013
- Atlas of Genetics and Cytogenetics in Oncology and Haematology in 2013Nucleic Acids Research, 2012
- Fanconi anemia proteins FANCD2 and FANCI exhibit different DNA damage responses during S-phaseNucleic Acids Research, 2012
- Mutational Processes Molding the Genomes of 21 Breast CancersCell, 2012
- Diagnostic Overlap between Fanconi Anemia and the Cohesinopathies: Roberts Syndrome and Warsaw Breakage SyndromeAnemia, 2010
- Malignancies and survival patterns in the National Cancer Institute inherited bone marrow failure syndromes cohort studyBritish Journal of Haematology, 2010
- Fanconi anemia and its diagnosisMutation Research - Reviews in Mutation Research, 2009
- Deubiquitination of FANCD2 Is Required for DNA Crosslink RepairMolecular Cell, 2007
- Analysis ofPALB2/FANCN-associated breast cancer familiesProceedings of the National Academy of Sciences of the United States of America, 2007
- Histone H2AX and Fanconi anemia FANCD2 function in the same pathway to maintain chromosome stabilityThe EMBO Journal, 2007